Antiarrhythmic Therapy in Acute Myocardial Infarction: Individualised Treatment with Lidocaine

  • R. Ritz
  • F. Follath
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 1)


The initial impetus for the establishment of the first Coronary Care Units in 1962 in Kansas City, Toronto and Philadelphia came about from the recognition that many patients with acute myocardial infarction died suddenly. It was therefore hoped that resuscitative efforts could reverse this remarkable mortality trend. The complementary goal was to provide immediate therapy for cardiac arrhythmias assumed to be the cause of sudden death in these patients [8]. Later the concept of treating the so-called “warning arrhythmias” — which means ventricular dysrhythmias leading to ventricular fibrillation — received considerable support, although the significance and treatment of these ectopic beats remain an important and controversial issue [10]. However as long as we believe in the significance of the so-called warning arrhythmias (e.g. ventricular premature beats ≥ Lown III) [11] during the first phase of acute myocardial infarction we should recognize them properly and treat them by the correct antiarrhythmic drug in the correct dosage.


Acute Myocardial Infarction Coronary Care Unit Antiarrhythmic Therapy Correct Dosage Ventricular Premature Beat 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Chernow B (ed) (1983) The Pharmacologic Approach to the Critically Ill Patient. Williams and Wilkins, BaltimoreGoogle Scholar
  2. 2.
    Dalen JE, Goldberg RJ et al (1984) Therapeutic Interventions in Acute Myocardial Infarction. Chest 8ó: 257–262Google Scholar
  3. 3.
    De Silva RA, Lown B et al (1981) Lignocaine Prophylaxis in Acute Myocardial Infarction: An Evaluation of Randomised Trials. Lancet 2: 855–858Google Scholar
  4. 4.
    Follath F, Ritz R et al (1981) Verbesserte Lidocaindosierung durch Serumkonzentrationsbestimmungen bei Patienten mit Myokardinfarkt. Verh Dtsch Ges Inn Med 87: 427–429Google Scholar
  5. 5.
    Follath F, Ritz R et al (1982) Verlangsamte Lidocain-Elimination and Dosisanpassung bei Patienten mit Herzinsuffizienz. Schweiz Med Wschr 112: 789–791PubMedGoogle Scholar
  6. 6.
    Gianelly R, Groeben JO et al (1967) Effect of lignocaine on ventricular arrhythmias in patients with coronary heart disease. N Engl J Med 277: 1215–1219PubMedCrossRefGoogle Scholar
  7. 7.
    Harrison DC (1978) Should Lidocaine be Administered Routinely to Patients after Acute Myocardial Infarction? Circulation 58: 581–584PubMedCrossRefGoogle Scholar
  8. 8.
    Karliner JS, Gregoratos G (1981) Coronary Care. Churchill Livingstone New YorkGoogle Scholar
  9. 9.
    Lie KI, Wellens HJ et al (1974) Lidocaine in the prevention of Primary Ventricular Fibrillation. N Engl J Med 291: 1324–1326PubMedCrossRefGoogle Scholar
  10. 10.
    Lie KI, Wellens HJ et al (1975) Observations on Patients with Primary Ventricular Fibrillation Complicating Acute Myocardial Infarction. Circulation 52: 755–759PubMedCrossRefGoogle Scholar
  11. 11.
    Lown B, Klein MD et al (1969) Coronary and Precoronary Care. Am J Med 46: 705–708CrossRefGoogle Scholar
  12. 12.
    Noneman JW, Rogers JF (1978) Lidocaine Prophylaxis in Acute Myocardial Infarction. Medicine 57: 501–515PubMedCrossRefGoogle Scholar
  13. 13.
    Ritz R (1981) Qualitätskontrolle einer rechnergestützten Arrhythmie-Ueberwachung. Schweiz Med Wschr 111: 997–1000PubMedGoogle Scholar
  14. 14.
    Ritz R, Bernet F et al (1982) Wirksamkeit der antiarrhytmischen Therapie mit Lidocain beim akuten Myokardinfarkt. Schweiz Med Wschr 112: 1638 (abstract)Google Scholar
  15. 15.
    Ritz R (19847 Clinical Experience with Computerized ICU-monitoring. Resuscitation 11:249–253Google Scholar
  16. 16.
    Romhildt D W, Bloomfield S S, Chou T, Fowler N O (1973) Unreability of Conventional Electrocardiographic Monitoring for Arrhythmia Detection in Coronary Care Units. Amer J Cardiol 31: 457–461CrossRefGoogle Scholar
  17. 17.
    Shah P M, Arnold J M et al (1977) Automatic Real Time Arrhythmia Monitoring in the Intensive Coronary Care Unit. Amer J Cardiol 39: 701–708PubMedCrossRefGoogle Scholar
  18. 18.
    Sheiner L B, Rosenberg B et al (1972) Modelling of individual pharmacokinetics for computer aided drug dosage. Computer Biomedical Research 5: 441–459CrossRefGoogle Scholar
  19. 19.
    Sheiner L B, Rosenberg B et al (1977) Estimation of population characteristics of pharmacokinetics parameters from routine clinical data. J Pharmacokin Biopharm 5: 445–479Google Scholar
  20. 20.
    Vaughan-Williams E M (1975) Classification of antidysrhytmic drugs. J Pharmacol Ther 1: 115–138Google Scholar
  21. 21.
    Vetter N J, Julian D G (1975) Comparison of Arrhythmia Computer and Conventional Monitoring in Coronary Care Unit. Lancet 1: 1151–1154PubMedCrossRefGoogle Scholar
  22. 22.
    Vozeh S, Muir K T et al (1981) Predicting individual phenytoin dosage. J Pharmacokinetics and Biopharmaceutics 9: 131CrossRefGoogle Scholar
  23. 23.
    Vozeh S, Berger M, Wenk M, Ritz R, Follath F (1984) Rapid Prediction of Individual Dosage Requirements for Lignocaine. Clin Pharmacokinetics 9: 354–363CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • R. Ritz
  • F. Follath

There are no affiliations available

Personalised recommendations